Not applicableStudy completedNCT02713295
What this trial is testing
Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie 273